[HTML][HTML] New blood biomarkers for the diagnosis of AFP-negative hepatocellular carcinoma

T Wang, KH Zhang - Frontiers in Oncology, 2020 - frontiersin.org
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

[HTML][HTML] New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

T Wang, KH Zhang - Frontiers in Oncology, 2020 - ncbi.nlm.nih.gov
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

T Wang, KH Zhang - Frontiers in oncology, 2020 - pubmed.ncbi.nlm.nih.gov
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma. Front

T Wang, KH Zhang - … of Novel Biomarkers for Pancreatic and …, 2022 - books.google.com
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …

[引用][C] New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma

T Wang, KH Zhang - Frontiers in Oncology, 2020 - cir.nii.ac.jp
New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.

T Wang, KH Zhang - Frontiers in Oncology, 2020 - europepmc.org
An early diagnosis of hepatocellular carcinoma (HCC) followed by effective treatment is
currently critical for improving the prognosis and reducing the associated economic burden …